You are viewing the site in preview mode

Skip to main content

Advertisement

Table 9 Costs of managing metastatic disease

From: The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

  Quantity p.a Price/unit (€) Total costs p.a. (€)
Responsive    
Out-patient    
Specialist practitioner 4 See above 128.28
Medication    
LHRH Agonist leuprorelin 4 415 1,660
Refractory    
Medication    
Docetaxel 17.3 1768 30,645.3
Prednisolon 0.87 10.6 9.2
Bone metastases    
Out-patient    
Radiation 14 See Table 5 1,484.06
In-patient    
Bone scan 0.7 1629.65 1,140.76
Medication    
Zoledron acid 12 367.98 4,415.76
  1. LHRH = Luteinizing Hormone-Releasing Hormone.